Liquidmetal Technologies Inc (LQMT)

[JoTu]

Management Commentary

Dr. Bruce Bromage, the Company’s Chief Operating Officer, stated that “the third quarter of 2018 showed the Company’s continued execution of our commercialization strategy. Early production orders shipped during the quarter for Amorphous Metal Molding (AMM) and Metal Injection Molding (MIM) customers. In addition, the Company has active development projects with top-tier medical, automotive and consumer products companies, each with potential for volume, multi-year production.”

Dr. Bromage continued that “several projects are underway in collaboration with Yihao Metals, taking advantage of Liquidmetal’s amorphous metals expertise and proximity to US customers to develop parts that can be produced in high volumes in Asia. Liquidmetal and Yihao are working together to improve the cost of commercial AMM machines, alloys and processing methods to open markets globally.”

Q3 2018 Financial Summary
During the third quarter of 2018, the Company generated $253 thousand in revenue through completion of the production tooling portion of commercial orders for both our AMM and MIM platforms. During the third quarter of 2018, we finished validation procedures for the Company’s first eight-cavity mold, highlighting our development efforts and continued emergence as a volume manufacturer.

conmed or arthrex
place your bets folks